Institute Of Tropical Medicine, Belgium
Clinical trials sponsored by Institute Of Tropical Medicine, Belgium, explained in plain language.
-
Rabies vaccine booster still effective years later, new study aims to prove
⭐️ VACCINE ⭐️ Not yet recruitingThis study checks if a single rabies booster shot can still protect people who got their first rabies vaccines at least five years ago. About 561 healthy adults will receive one booster dose. Researchers will measure immune response 7 and 14 days later to see if the body remember…
Phase: PHASE3 • Sponsor: Institute of Tropical Medicine, Belgium • Aim: ⭐️ VACCINE ⭐️
Last updated May 16, 2026 23:37 UTC
-
New hope for skin disease: major trial tests 4 treatments
Disease control Not yet recruitingThis large Phase 3 trial in Ethiopia will test four different drug combinations against the standard treatment for cutaneous leishmaniasis, a skin disease caused by a parasite. About 900 people aged 4 to 65 with confirmed infection will be hospitalized and treated for up to 180 d…
Phase: PHASE3 • Sponsor: Institute of Tropical Medicine, Belgium • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New 15-minute plague test could save lives in remote congo villages
Diagnosis Not yet recruitingThis study will test a new rapid diagnostic test for plague in the Ituri province of DR Congo. Researchers will collect samples (blood, saliva, mouth swab, bubo fluid, and sputum) from 300 people with suspected plague to see how well the new test works compared to standard lab me…
Sponsor: Institute of Tropical Medicine, Belgium • Aim: Diagnosis
Last updated May 12, 2026 13:42 UTC
-
Mpox booster shot under the microscope: 2-Year immune watch begins
Knowledge-focused Not yet recruitingThis study will follow 95 adults who receive a booster dose of the MVA-BN vaccine against mpox. Researchers will collect blood and other samples over two years to track how the immune system responds. The goal is to understand how long protection lasts after a booster, not to tes…
Sponsor: Institute of Tropical Medicine, Belgium • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Mpox vaccine immunity under the microscope: new study tracks protection
Knowledge-focused Not yet recruitingThis study will follow 300 adults in Kinshasa, DRC, who received either the MVA-BN or LC16m8 mpox vaccine as part of routine vaccination. Researchers will collect blood samples at several time points to measure how strong and long-lasting the immune response is. The goal is to be…
Phase: PHASE4 • Sponsor: Institute of Tropical Medicine, Belgium • Aim: Knowledge-focused
Last updated May 07, 2026 18:42 UTC